Enjoy complimentary customisation on priority with our Enterprise License!
The global vitamin D testing market size is estimated to grow by USD 193.53 million at a CAGR of 5.44% between 2022 and 2027.
One of the major reasons for the large-scale incidence of several nutritional disorders is lack of awareness. Promoting awareness among people about the importance of essential nutrients such as vitamin D which have a major role to play in improving health around the world is very important. One of the main growth drivers in vitamin D testing markets is increasing awareness. Various awareness programs run by the government and non-government organizations, educational campaigns about vitamin D sources, benefits, and consequences of its deficiency and insufficiency at the community level targeting both high-risk and general population have further enabled in preventing long-term health consequences. The increased awareness of vitamin D has also been made possible by an increase in internet penetration among end users.
Technavio has segmented the market into Product, End-user, and Geography segments.
It also includes an in-depth analysis of drivers, trends, and challenges.
To learn more about this report, Request Free Sample
The market share growth by the 25-hydroxyvitamin D segment will be significant during the forecast period. 25-hydroxyvitamin D testing was the largest segment of the global vitamin D testing market in 2022 and will continue to be the largest segment during the forecast period. One of the nutrients needed for human health is vitamin D, which helps to facilitate functions such as cell growth modulation, neuromuscular and immune function, or reduction in inflammation. Several genes encoding proteins that regulate cell differentiation, proliferation, and apoptosis are modulated in part by vitamin D.
Get a glance at the market contribution of various segments View a PDF Sample
The 25-hydroxyvitamin D segment was valued at USD 409.88 million in 2017. Two bioequivalent forms of vitamin D, namely vitamin D2, known as ergocalciferol, are obtained from plant-based food sources and oral supplements. Vitamin D3, known as cholecalciferol, is released primarily through skin exposure to ultraviolet B (UVB) radiation found in sunlight and through the consumption of vitamin-rich foods such as fatty fish, fortified foods, and oral supplements. Both vitamins D2 and D3 are biologically inactive and are chemically converted in the liver to 25-hydroxyvitamin D (calcidiol) and then to 1,25-hydroxyvitamin D (calcitriol) in the kidneys. Various market players Various are offering innovative products to meet the end-users expectations. The increasing prevalence of osteomalacia and rickets among children will drive the growth of the 25-hydroxyvitamin D testing segment of the global vitamin D testing market during the forecast period.
Diagnostic laboratories include independent testing laboratories and play an important role in the global vitamin D testing market by offering efficient services such as quantitative chemiluminescent immunoassay. These laboratories require robust and efficient testing instruments such as analyzers, spectroscopes, centrifuges, and liquid handling systems to obtain precise results as per the standards. Furthermore, vitamin D tests performed in diagnostic laboratories may use radioactive isotopes such as I-125 as tracers and require highly skilled laboratory professionals for effective laboratory management. A shortage of trained professionals poses a significant challenge and could negatively impact increased sales of laboratory-dedicated vitamin D testing products. However, training of testing professionals mandated by agencies such as the Centers for Disease Control and Prevention (CDC) could overcome such problems and facilitate the rapid growth of vitamin D testing in the diagnostic testing sector during the forecast period.
The rising hospitalization rate, due to the prevalence of chronic conditions such as diabetes, rickets, and osteoporosis, has resulted in a rising number of vitamin D testing procedures in hospitals and physician clinics, as vitamin D levels are closely related to such conditions. Moreover, rising access to acute care facilities owing to their growing number further aided in promoting vitamin D testing in hospitals. Furthermore, the benefits of integrated care and personal consultations have increased the demand for vitamin D testing in clinics and are expected to boost the adoption of vitamin D testing in hospitals and physician clinics segment during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The North American vitamin D testing market has been led by the US due to the presence of numerous vendors such as Abbott, Danaher, and Quest Diagnostics Inc., which offer a wide range of vitamin D testing products in the region. According to the CDC, 25% of the US population is at risk of insufficient vitamin D, and 8% are at risk of deficiency, as defined by the Dietary Reference Intake (DRI) set by the Institute of Medicine. Similarly, the US Department of Agriculture (USDAs) National Nutrient Database highlights the nutrient content of a range of foods and provides an all-inclusive list of foods containing vitamin D arranged by the name of the food and its nutrient content.
Moreover, several studies have shown that vitamin D deficiency is a contributing factor to the development of type 1 and type 2 diabetes, with high rates of diabetes associated with low vitamin D levels in patients in this region. Furthermore, due to the increasing awareness about vitamin D testing, the e US is followed by Canada in terms of revenue contribution. For instance, the Vitamin D Society, a non-profit organization in Canada, works to grow awareness about many health conditions, which are linked to vitamin D deficiency, and encourage all the people in Canada to be proactive and get their vitamin D blood levels tested annually. All these factors are expected to drive the growth of the market in North America.
In 2020, the regional vitamin D testing market witnessed a slight slowdown in growth due to the outbreak of the COVID-19 pandemic. However, in 2021, the initiation of large-scale vaccination drives?lifted the lockdown and helped the market focus recover to a certain extent. Moreover, rising government initiatives to fuel economic growth and the adoption of innovative strategies for supply chain networks will drive the growth of the regional vitamin D testing market during the forecast period.
Buy Now Full Report and Discover More
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market vendors, including:
Beckman Coulter Inc.: The company offers vitamin D testing solution namely Access 25(OH) Vitamin D Total Assay
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The growing prevalence of vitamin D deficiency-related disorders is the key factor driving the growth of the market. Vitamin D deficiency is associated with serious health disorders such as rickets. Rickets is a disease in which bone tissue fails to mineralize properly, causing weak bones and skeletal deformities, especially in children. In addition, a growing number of research studies on vitamin D deficiency have been shown to be associated with several health problems. Low vitamin D levels in the blood are thought to increase the risk of cardiovascular disease, cognitive impairment in the elderly, severe asthma in children, and cancer.
Furthermore, healthcare professionals also routinely test people for vitamin D deficiency because of musculoskeletal symptoms, such as bone pain, muscle aches, and general weakness. Additionally, vitamin D deficiency is associated with an increased risk of diabetes, immune system disorders, and neuropsychiatric disorders. Thus, the association of vitamin D deficiency with several health-related disorders is expected to boost the global vitamin D testing market during the forecast period.
A growing number of strategic developments by vendors is the primary trend in the global vitamin D testing market. Vendors are looking to expand their diagnostic and testing product portfolios through various inorganic growth strategies. M&A helps market players to focus on product innovation, grow profit margins through collaboration, and support technology sharing among players. Through the M&A, both companies will realize economies of scale through large-scale production and distribution, lowering unit prices for vitamin D testing products. As a result, companies like Abbott and bioMerieux are focused on growing product sales through mergers and acquisitions.
Moreover, remarkable M and A activity have been observed in the global vitamin D testing market. These activities will help the market players to grow and expand their global footprint and leverage existing distribution channels and customer relationships to better serve the needs of patients and caregivers. Thus, the growing number of M and A activities by major players will strengthen the diagnostic capabilities of the company, which will boost the growth of the global vitamin D testing market during the forecast period.
Product recalls pose challenges to manufacturers that affect the growth of the global vitamin D testing market. Product recalls impacting on both consumer confidence and a company's brand image, thus impacting both a company's revenue and long-term prospects. This, in turn, affects product sales. Such product recalls hinder the product innovation process of manufacturers and allow competitors to accelerate their innovation efforts to exploit these weaknesses. Timely innovation gives companies a significant advantage in the competitive market.
Moreover, the US FDA recalls products that pose potential health risks to users due to manufacturing defects. wrong reported vitamin D levels can lead to inaccurate vitamin supplement dosages and can lead to serious health problems. Additionally, recall occurrences can become pitfalls and lead to a significant loss for vendors, which will be impeding the growth of the global vitamin D testing market during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Vitamin D Testing Market Customer Landscape
The vitamin D testing market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Vitamin D Testing Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.44% |
Market growth 2023-2027 |
USD 193.53 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
4.5 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Beckman Coulter Inc., Biohit Oyj, bioMerieux SA, BioVendor Laboratorni medicina AS, Boditech Med Inc., DiaSorin SpA, DiaSys Diagnostic Systems GmbH, Everly Health Inc., F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Perkin Elmer Inc., Qualigen Therapeutics Inc., Quest Diagnostics Inc., Quidelortho Corp., Randox Laboratories Ltd., Recipe Chemicals and Instruments GmbH, Siemens AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Tosoh Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.